Kowal Investment Group’s Avanos Medical AVNS Stock Holding History

Kowal Investment Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-139	Closed	-$4K	–	184
2021 Q3	$4K	Buy	+139	New	+$4.72K	﹤0.01%	680

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Kowal Investment Group's AVNS Position: Q4 2021 in Review

Kowal Investment Group sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 139 shares — an estimated $4K sold.

Kowal Investment Group first reported a position in AVNS in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

Kowal Investment Group reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 139 Avanos Medical shares in Q4 2021, an estimated $4K.
Kowal Investment Group first reported a position in Avanos Medical in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Avanos Medical position peaked at $4K in Q3 2021.
297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.